207 related articles for article (PubMed ID: 27801732)
21. Hes3 Enhances the Malignant Phenotype of Lung Cancer through Upregulating Cyclin D1, Cyclin D3 and MMP7 Expression.
Fang C; Jiang B; Shi X; Fan C
Int J Med Sci; 2019; 16(3):470-476. PubMed ID: 30911281
[No Abstract] [Full Text] [Related]
22. [Association of HAb18G with clinicopathologic features and prognosis in non-small cell carcinoma of lung].
Xu XY; Zhi C; Li YM; Qi WJ; Mei JJ; Yan ZM; Shen H
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):151-5. PubMed ID: 22800476
[TBL] [Abstract][Full Text] [Related]
23. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
25. Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal?
Kawase A; Yoshida J; Ishii G; Nakao M; Aokage K; Hishida T; Nishimura M; Nagai K
Jpn J Clin Oncol; 2012 Mar; 42(3):189-95. PubMed ID: 22210923
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.
Kinoshita T; Ohtsuka T; Yotsukura M; Asakura K; Goto T; Kamiyama I; Otake S; Tajima A; Emoto K; Hayashi Y; Kohno M
J Thorac Oncol; 2015 Apr; 10(4):619-28. PubMed ID: 25634009
[TBL] [Abstract][Full Text] [Related]
27. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889
[TBL] [Abstract][Full Text] [Related]
28. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
[TBL] [Abstract][Full Text] [Related]
29. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
31. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
[TBL] [Abstract][Full Text] [Related]
32. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer.
Raungrut P; Wongkotsila A; Lirdprapamongkol K; Svasti J; Geater SL; Phukaoloun M; Suwiwat S; Thongsuksai P
Asian Pac J Cancer Prev; 2014; 15(8):3513-8. PubMed ID: 24870749
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
[TBL] [Abstract][Full Text] [Related]
35. Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.
Noh SJ; Baek HA; Park HS; Jang KY; Moon WS; Kang MJ; Lee DG; Kim MH; Lee JH; Chung MJ
Pathol Res Pract; 2013 Jun; 209(6):365-70. PubMed ID: 23702379
[TBL] [Abstract][Full Text] [Related]
36. Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance.
Guo F; Hiroshima K; Wu D; Satoh M; Abulazi M; Yoshino I; Tomonaga T; Nomura F; Nakatani Y
Hum Pathol; 2012 Aug; 43(8):1282-8. PubMed ID: 22304787
[TBL] [Abstract][Full Text] [Related]
37. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
38. DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
Li D; Yang Z; Liu Z; Zou Q; Yuan Y
Pathol Oncol Res; 2019 Jan; 25(1):157-167. PubMed ID: 29043607
[TBL] [Abstract][Full Text] [Related]
39. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of cytoplasmic PLZF correlates with high tumor grade and tumor aggression in non-small cell lung carcinoma.
Xiao GQ; Li F; Findeis-Hosey J; Hyrien O; Unger PD; Xiao L; Dunne R; Kim ES; Yang Q; McMahon L; Burstein DE
Hum Pathol; 2015 Nov; 46(11):1607-15. PubMed ID: 26297253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]